Patents by Inventor M. Marshall

M. Marshall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240141127
    Abstract: Disclosed are foamable compositions that can be particularly beneficial for foam-in-place packaging purposes. The foamable compositions can be reacted to form a polyurethane foam that can be utilized to secure packaging contents inside a transport packages, and that at a later time can be readily decomposed at low degradation temperatures, e.g., about 90° C. or less. The polyurethane foam can also act as a sink for hydrogen radicals and as such can be utilized for transport of high energy emitting materials, e.g., ?-radiating materials.
    Type: Application
    Filed: October 13, 2022
    Publication date: May 2, 2024
    Inventors: EDWARD T. KETUSKY, MARK D. KRANJC, JAMES M. SHULER, NICHOLAS M. MARSHALL
  • Publication number: 20240115493
    Abstract: The oral cavity is an ideal-site for small molecule, nutrient/nutraceutical delivery to the central nervous system (CNS) and systemic circulation due to the highly-vascularized, oral mucosa, near-neutral pH conditions, close proximity to the brain, and avoidance of gastric degradation and the first-pass effect. The rich-blood supply of the oral mucosa and “sticky”, mucoadhesive properties of this novel, saccharide-based, delivery system allows for the efficient absorption of small molecules across several highly-vascularized surfaces including the gingival, sublingual, soft-palatal, and buccal mucosa. Herein, I introduce a novel, saccharide-based, food-form, palatable, easy-to-administer, oral delivery system that attaches to these four, highly-absorptive surfaces for a longer contact-duration than current orally-available formulas resulting in greater, small molecule bioavailability, and a more rapid, therapeutic effect.
    Type: Application
    Filed: December 19, 2023
    Publication date: April 11, 2024
    Inventor: Timothy M. Marshall
  • Publication number: 20240108576
    Abstract: The present disclosure relates to the field of oral mucoadhesive dosage forms and the type and amounts of structural components to improve mucoadhesion. The present disclosure further relates to combinations of active ingredients within a mucoadhesive dosage form.
    Type: Application
    Filed: December 13, 2023
    Publication date: April 4, 2024
    Inventor: Timothy M. MARSHALL
  • Publication number: 20230344722
    Abstract: Techniques are disclosed for generating device cluster capability information for a cluster of devices in a network environment. Capability information can specify capabilities of the devices in the cluster. A first user device can generate device capabilities for the first user device and obtain device capabilities for other devices in the cluster. The first user device can generate cluster capability information providing an intersection of the first set of device capabilities and device capabilities of the other user devices in the cluster. The first user device can obtain cluster capability information for other clusters in the network environment and receive a request from a service user device to perform a specific task. The first user device can transmit cluster capability information relating to a selected cluster that corresponds with the request.
    Type: Application
    Filed: June 29, 2023
    Publication date: October 26, 2023
    Applicant: Apple Inc.
    Inventors: Scott M. Marshall, Jeremy A. Wyld, Jiten L. Mehta, Darren Litzinger, John J. Iarocci
  • Patent number: 11773445
    Abstract: In one aspect the invention relates to the use of single nucleotide polymorphisms (SNPs) in transient receptor potential (TRP) ion channel, acetylcholine receptor (AchR) and/or adrenergic receptor (ADR) genes as probes, tools or reagents for identifying, screening, diagnosing, monitoring or managing/treating subjects with, or predisposed to, medical conditions (or symptoms thereof), such as chronic fatigue syndrome (CFS), myalgic encephalomyelitis (ME), Gulf war syndrome (GWS), irritable bowel syndrome (IBS), multiple chemical sensitivity (MCS), fibromyalgia, and migraine, as well as some medical conditions caused by dysregulation in calcium, acetylcholine, TRP and ADR, and dysregulation in the gastrointestinal, cardiovascular, neurological, genitourinary and immune systems. In another aspect the invention relates to methods, kits and assays for identifying, screening, diagnosing, monitoring or managing/treating subjects with one or more of those medical conditions or symptoms.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: October 3, 2023
    Inventors: Sonya M. Marshall-Gradisnik, Donald R. Staines, Peter Kenneth Smith
  • Patent number: 11736361
    Abstract: Techniques are disclosed for generating device cluster capability information for a cluster of devices in a network environment. Capability information can specify capabilities of the devices in the cluster. A first user device can generate device capabilities for the first user device and obtain device capabilities for other devices in the cluster. The first user device can generate cluster capability information providing an intersection of the first set of device capabilities and device capabilities of the other user devices in the cluster. The first user device can obtain cluster capability information for other clusters in the network environment and receive a request from a service user device to perform a specific task. The first user device can transmit cluster capability information relating to a selected cluster that corresponds with the request.
    Type: Grant
    Filed: December 13, 2022
    Date of Patent: August 22, 2023
    Assignee: Apple Inc.
    Inventors: Scott M. Marshall, Jeremy A. Wyld, Jiten L. Mehta, Darren Litzinger, John J. Iarocci
  • Patent number: 11686470
    Abstract: A boiler includes a steam drum, an intermediate drum, and a lower drum. Each drum is divided into a clean section and a concentrated section. A channel that is fluidly connected to the clean section also runs down one side of the concentrated section in the intermediate drum and the lower drum. The presence of the channels permits low-quality feedwater tubes and high-quality feedwater tubes to be arranged in parallel rows next to each other.
    Type: Grant
    Filed: February 3, 2020
    Date of Patent: June 27, 2023
    Assignee: The Babcock & Wilcox Company
    Inventors: Melvin J Albrecht, Jason M Marshall, Jonathan B Ford, Jeremy L Remus
  • Publication number: 20230084026
    Abstract: Systems and methods provide customizable package options according to consumer preferences. Demand simulators may be used to guide the creation of selectable graphical objects representing optimized packages of features, which users may select from to form an insurance product appropriate for their particular needs. Packages may be formed with a particular appeal to consumers with common characteristics. In addition, methods and systems are provided for presenting insurance packages for consideration by customers over a network. Presented insurance packages may be formed through an optimization process or according to customer preferences.
    Type: Application
    Filed: October 24, 2022
    Publication date: March 16, 2023
    Inventors: Floyd M. Yager, Thomas J. Wilson, Pamela M. Marshall, Sara P. Drexler
  • Patent number: 11582110
    Abstract: Techniques are disclosed for generating device cluster capability information for a cluster of devices in a network environment. Capability information can specify capabilities of the devices in the cluster. A first user device can generate device capabilities for the first user device and obtain device capabilities for other devices in the cluster. The first user device can generate cluster capability information providing an intersection of the first set of device capabilities and device capabilities of the other user devices in the cluster. The first user device can obtain cluster capability information for other clusters in the network environment and receive a request from a service user device to perform a specific task. The first user device can transmit cluster capability information relating to a selected cluster that corresponds with the request.
    Type: Grant
    Filed: March 18, 2022
    Date of Patent: February 14, 2023
    Assignee: Apple Inc.
    Inventors: Scott M. Marshall, Jeremy A. Wyld, Jiten L. Mehta, Darren Litzinger, John J. Iarocci
  • Publication number: 20230026007
    Abstract: The present invention provides engineered galactose oxidase (GOase) enzymes, polypeptides having GOase activity, and polynucleotides encoding these enzymes, as well as vectors and host cells comprising these polynucleotides and polypeptides. Methods for producing GOase enzymes are also provided. The present invention further provides compositions comprising the GOase enzymes and methods of using the engineered GOase enzymes. The present invention finds particular use in the production of pharmaceutical and other compounds.
    Type: Application
    Filed: September 9, 2022
    Publication date: January 26, 2023
    Inventors: Christopher Michael Micklitsch, Oscar Alvizo, Jovana Nazor, Harvinder Chagger Maniar, Mikayla Jianghongxia Krawczyk, Margie Tabuga Borra-Garske, Nandhitha Subramanian, Anna Fryszkowska, Nicholas M. Marshall, Agustina Rodriguez-Granillo, Deeptak Verma, Dewan Andrews
  • Patent number: 11506128
    Abstract: A starter assembly for a gas turbine engine according to an example of the present disclosure includes, among other things, a fluid-actuated starter coupled to a spool, and a controller operable to cause a reduction in torque output of the starter in response to determining that a first threshold is met. The first threshold relates to an engine operational condition. A method for starting a gas turbine engine is also disclosed.
    Type: Grant
    Filed: August 19, 2021
    Date of Patent: November 22, 2022
    Assignee: RAYTHEON TECHNOLOGIES CORPORATION
    Inventors: Andre M. Ajami, Sami Chukrallah, Richard M. Marshall, Ryan W. Hunter
  • Publication number: 20220363782
    Abstract: Heterodimerizing domains with orthogonal mutations that drive heterodimerization, in particular heterodimerizing antibody CH3 domains, heterodimeric polypeptides comprising such heterodimerizing domains, and antibody constructs comprising such heterodimeric polypeptides, are provided.
    Type: Application
    Filed: December 10, 2021
    Publication date: November 17, 2022
    Inventors: Jonathan Harry DAVIS, Nicholas M. MARSHALL
  • Patent number: 11499502
    Abstract: A gas turbine engine system according to an exemplary aspect of the present disclosure may include a core engine defined about an axis, a fan driven by the core engine about the axis to generate bypass flow, and at least one integrated mechanism in communication with the bypass flow. The at least one integrated mechanism includes a variable area fan nozzle (VAFN) and thrust reverser, and a plurality of positions to control bypass flow.
    Type: Grant
    Filed: June 8, 2020
    Date of Patent: November 15, 2022
    Assignee: RAYTHEON TECHNOLOGIES CORPORATION
    Inventor: Richard M. Marshall
  • Publication number: 20220331235
    Abstract: The present disclosure relates to the field of oral mucoadhesive dosage forms and the type and amounts of structural components to improve mucoadhesion. The present disclosure further relates to combinations of active ingredients within a mucoadhesive dosage form.
    Type: Application
    Filed: March 8, 2022
    Publication date: October 20, 2022
    Inventor: Timothy M. MARSHALL
  • Patent number: 11466259
    Abstract: The present invention provides engineered galactose oxidase (GOase) enzymes, polypeptides having GOase activity, and polynucleotides encoding these enzymes, as well as vectors and host cells comprising these polynucleotides and polypeptides. Methods for producing GOase enzymes are also provided. The present invention further provides compositions comprising the GOase enzymes and methods of using the engineered GOase enzymes. The present invention finds particular use in the production of pharmaceutical and other compounds.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: October 11, 2022
    Assignee: Codexis, Inc.
    Inventors: Christopher Michael Micklitsch, Oscar Alvizo, Jovana Nazor, Harvinder Chagger Maniar, Mikayla Jianghongxia Krawczyk, Margie Tabuga Borra-Garske, Nandhitha Subramanian, Anna Fryszkowska, Nicholas M. Marshall, Agustina Rodriguez-Granillo, Deeptak Verma, Dewan Andrews
  • Publication number: 20220303186
    Abstract: Techniques are disclosed for coordinating state information between devices in a network of devices. In one example, a first user device can obtain event information identifying an event (e.g., triggering of an alarm) associated with another user device and state information identifying a state of the other device. The first user device can report the state and event information to devices in the network. Observers corresponding to each user device can identify the occurrence of the event corresponding to the event information for each user device. An action (e.g., output an audio chime) can be performed by each device with an observer that identifies the occurrence of the event corresponding to the event information for each user device.
    Type: Application
    Filed: March 18, 2022
    Publication date: September 22, 2022
    Applicant: Apple Inc.
    Inventors: Scott M. Marshall, Jiten L. Mehta, Darren S. Litzinger, Jeremy A. Wyld, John J. Iarocci
  • Publication number: 20220303185
    Abstract: Techniques are disclosed for generating device cluster capability information for a cluster of devices in a network environment. Capability information can specify capabilities of the devices in the cluster. A first user device can generate device capabilities for the first user device and obtain device capabilities for other devices in the cluster. The first user device can generate cluster capability information providing an intersection of the first set of device capabilities and device capabilities of the other user devices in the cluster. The first user device can obtain cluster capability information for other clusters in the network environment and receive a request from a service user device to perform a specific task. The first user device can transmit cluster capability information relating to a selected cluster that corresponds with the request.
    Type: Application
    Filed: March 18, 2022
    Publication date: September 22, 2022
    Applicant: Apple Inc.
    Inventors: Scott M. Marshall, Jeremy A. Wyld, Jiten L. Mehta, Darren Litzinger, John J. Iarocci
  • Patent number: 11415314
    Abstract: A boiler includes an upper steam drum, an optional intermediate drum, and a lower drum. Each drum is divided by an internal divider into a clean section and a concentrated section. Downcomers connect the upper steam drum to the lower drum, and tubes are connected to convey a heated steam-water mixture from the lower drum into the upper steam drum (through the optional intermediate drum, if provided). An optional superheater has an input terminal connected to receive steam from the clean section of the upper steam drum. An attemperator may be provided to attemperate superheated steam output from an output terminal of the superheater, and the attemperation fluid may optionally be provided from the concentrated side of the upper steam drum.
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: August 16, 2022
    Assignee: The Babcock & Wilcox Company
    Inventors: Melvin J Albrecht, Jason M Marshall, Jeremy L Remus
  • Publication number: 20220118006
    Abstract: Neuroprotective preparations (formulations) employing the synergistic, neurotrophic benefits of nutritional lithium With bioavailable magnesium (FIG. 1). The biological synergism of lithium and magnesium is further enhanced with a proprietary base of synergistic, neurotrophic nutrients. A highly-effective, trans-mucosal, delivery system is included to provide exceptional bioavailability of a palatable, convenient intra-oral preparation, which saturates the vascular tissue in the oral cavity for efficient absorption. Additionally, methods of use are described, allowing for effective, safe, and convenient use of this novel, neuroprotective, antioxidant, anti-inflammatory preparation for humans and animals.
    Type: Application
    Filed: January 3, 2022
    Publication date: April 21, 2022
    Inventor: Timothy M. MARSHALL
  • Publication number: 20220090033
    Abstract: The present invention provides engineered transaminase polypeptides and compositions thereof, as well as polynucleotides encoding the engineered transaminase polypeptides. Methods for producing transaminase enzymes are also provided. In some embodiments, the engineered transaminase polypeptides are optimized to provide improved enzyme properties under minimal aqueous conditions in wet organic solvents.
    Type: Application
    Filed: January 13, 2020
    Publication date: March 24, 2022
    Inventors: Jovana Nazor, Christopher Michael Micklitsch, Da Duan, Auric Anthony Sowell-Kantz, Steven Miller, Birgit Kosjek, Inman Farasat, Nicholas M. Marshall